Managing Amyloidosis in 2024: Diagnosis and Treatment

Indy Hematology Review

M. Gertz

Overview of Monoclonal Gammopathies From MGUS to Smoldering Myeloma

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

M. Kwok

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Indy Hematology Review

R. Birhiray

ASH 2023 Summary: "Practice Changing Updates in MM, SMM and MGUS Fro…

Insights from 2023 ASH Annual Meeting

R. Banerjee

POEMS Syndrome Management

MyCancerHaven

R. Vij, D. Dingli

Lung Involvement in Amyloidosis

Houston Methodist

H. Huang

Key Myeloma & MGUS Updates From ASH

Memorial Sloan Kettering Cancer Center

S. Mailankody

Experts Discuss the Management of Monoclonal Gammopathy of Renal Sig…

MyCancerHaven

R. Vij, N. Leung

Management of AL Amyloidosis

GRACE

S. Rajeeve

Updates on AL Amyloidosis Treatment: What’s New in 2024

Dana-Farber Cancer Institute

G. Bianchi

Indy Hematology Review 2023: Plasma Cell Neoplasms and Amyloidosis U…

Indy Hematology Review

M. Gertz

"You Have AL-Amyloidosis": Counseling Newly Diagnosed Patients

Morie Gertz

Treating Amyloidosis in 2024

MyCancerHaven

R. Vij, J. Zonder

AL Amyloidosis Treatment Updates

Yale Cancer Center

T. Parker

Overview of Pathophysiology, Diagnosis and Management of Multiple My…

University of Colorado Division of Hematology

K. Sidor

Experts Discuss Novel Antibodies for the Management of Amyloidosis

MyCancerHaven

R. Vij, S. Lentzsch

Renal AL Amyloid

Yale Cancer Center

R. Luciano

Updates in the Management of SMM/MGUS and the Prevention of Progress…

Dana-Farber Cancer Institute

Y. Liu

ASH 2023 Insights: "iStopMM Study - Revised Definition of Free Light…

Insights from 2023 ASH Annual Meeting

T. Einarsson Long

Interpreting a PYP Study for TTR Cardiac Amyloid

American Society of Nuclear Cardiology

P. Soman, M. Harinstein, S. Divakaran